Stock Ratings / Consumer Discretionary / EVH / dividends

BLW (52) CSV (64) EVI (61) KLC (40) ⌘ Pro Terminal →

Evolent Health Inc (Class A) (EVH) Dividend Safety Gauge & 10-Year DRIP Compounder

$4.25 -1.85% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $4.23

Evolent Health Inc (Class A) (EVH) carries a Roarable Rating of D- (Sell) with 35/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (35/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D- • RED ALERT Cap $480.5M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $4.23 (-0.52%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 8/20 (D-) • 2.1% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (35/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-8.5% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk E

Each axis scored 0–20

12M PRICE TARGET CONE-10.4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for EVH)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (35/100 Composite)

🔍 WHY EVH SCORES 35/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Insider Conviction & Share Dilution+9/20 pts (26% of score)

SEC Form 4 / 13F Thermometer: 45% Net Buy • Disciplined Float (-0.40% YoY Shares)

▲ #2 Bullish Driver: Cash Engine Quality+8/20 pts (23% of score)

SEC XBRL FY 2025 (10-K): 2.1% FCF Margin ($38.8M FCF) & 21.3% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning5/20 pts (-15 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-15 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade E$4.04+13.1% Next Q

Q2 (-2Q)

Grade E$4.57+5% Next Q

Q3 (-1Q)

Grade E$4.80-11.5% Next Q

Current

Grade D-$4.25-8.5% Hist 90D α

Trajectory: E (27) → D- (35)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a EVH Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While EVH currently carries a cautious 35/100 (D-) rating due to Whale & Options Positioning (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Consumer Discretionary with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($4.20) and Max Pain ($4.46) forces dealer call-delta covering toward $7.23.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.40% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $EVH• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “EVH Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 35%NO 65%Trade / Inspect Odds →

CASH DIVIDEND + BUYBACK YIELD

1.8% Total Yield

0% Cash ($0.00/yr) + 1.8% Buybacks

PAYOUT SAFETY SPEEDOMETER

74/100 • REINVESTING IN GROWTH + BUYBACKS

FREE CASH FLOW PAYOUT RATIO

0% (100% Reinvested)

Retains cash flow for R&D and share repurchases

INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (5.5% EST. ANNUAL)

$10,000 Compounded Over 10 Years → $17,081

Est. Year-10 Shareholder Yield: $307/yr

Starting Investment: $10,000

Compounding Horizon: 10 Years

$10.6K

Yr 1

$11.1K

Yr 2

$11.7K

Yr 3

$12.4K

Yr 4

$13.1K

Yr 5

$13.8K

Yr 6

$14.5K

Yr 7

$15.3K

Yr 8

$16.2K

Yr 9

$17.1K

Yr 10

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring EVH)

✓Walkthrough of EVH's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

EVH // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +13.33%▲ ASCENDING CHANNEL

2026-10-30O $4.26H $4.31L $4.09C $4.25VOL 1.15M

RES: $5.14SUP: $3.49SMA50: $4.20SMA200: $3.87

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

EVH Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 EVH Butterfly Map → + Track EVH →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. -26.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on EVH today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for EVH. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for EVH today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (EVH)

Consumer Discretionary Rank #900 of 1011 ⚔️ BLW vs EVH Full Matrix →

1. Head-to-Head Consumer Discretionary Peer Comparison (EVH vs. BLW, CSV, EVI, KLC)

Industry: Other Consumer Services (73 Tracked Issuers)

Across 1011 tracked Consumer Discretionary securities in the Roarable RQD universe, Evolent Health Inc (Class A) (EVH) ranks #900 by composite RQD confidence (35/100, grade D-) and #592 by equity capitalization ($480.5M). Within this direct 5-issuer industry benchmark cohort, CSV leads on earnings valuation at 10.9x trailing P/E, while CSV leads on capital efficiency and profitability with 29.8% ROIC and 35.1% gross margin. CSV currently holds the highest overall quantitative score in the immediate peer group at 64/100 (C) compared with EVH at 35/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
EVH ACTIVE Evolent Health Inc (Class A)	D-	35/100	—	21.3%	-26.3%	-1.85%	$480.5M	Benchmark Subject
BLW Blackrock Limited Duration Income Trust	D+	52/100	—	—	—	+0.78%	$415.0M	/blw-vs-evh →
CSV Carriage Services Inc.	C	64/100	10.9x	35.1%	29.8%	-2.74%	$562.9M	/csv-vs-evh →
EVI EVI Industries Inc.	C-	61/100	37.3x	30.4%	5.4%	+1.26%	$279.7M	/evi-vs-evh →
KLC KinderCare Learning Companies Inc.	D-	40/100	—	—	-1.0%	+5.13%	$243.0M	/klc-vs-evh →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001628908

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Evolent Health Inc (Class A) (EVH) reported GAAP revenue of $1.88B (-26.6% vs. FY2024 revenue of $2.55B , and -4.5% cumulative change since FY2023) , GAAP net income of -$579.4M, operating cash flow of $38.8M, and free cash flow of $38.8M (+107.0% YoY). On the balance sheet, EVH closed FY2025 with $1.90B in total assets against $970.5M in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 4/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$1.88B	-$579.4M	$38.8M	$38.8M	$1.90B	$970.5M
FY2024 (FY)	2024-12-31	$2.55B	-$93.5M	$18.8M	$18.8M	$2.54B	$490.5M
FY2023 (FY)	2023-12-31	$1.96B	-$142.3M	$142.6M	$142.6M	—	—

3. EVH Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is EVH stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Evolent Health Inc (Class A) (NYSE: EVH) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 35/100 at a spot price of $4.25 (-1.85% 1D, market cap $480.5M). Pillar breakdown: Fundamental Cash Engine 8/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 6/20, FRED Macro Regime Fit 7/20, and SEC Balance-Sheet Forensics 9/20. Across 1011 tracked Consumer Discretionary issuers, EVH ranks #900 in composite RQD confidence.

How does EVH compare to BLW and CSV in the Consumer Discretionary sector?

Within the Consumer Discretionary sector (Other Consumer Services), EVH carries a Roarable D- (35/100 RQD), trailing P/E of N/A, gross margin of 21.3%, and ROIC of -26.3%. By comparison, BLW (Blackrock Limited Duration Income Trust) holds a D+ grade (52/100 RQD, P/E N/A, ROIC —, cap $415.0M) and CSV (Carriage Services Inc.) posts a C grade (64/100 RQD, P/E 10.9x, ROIC 29.8%, cap $562.9M). Among the 5-stock peer group, CSV leads on earnings multiple (10.9x) while CSV leads on capital efficiency (29.8% ROIC).

What are the biggest fundamental strengths and SEC risk factors for EVH?

Per EVH's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001628908), Evolent Health Inc (Class A) generated $1.88B in revenue (-26.6% YoY), -$579.4M in net income, and $38.8M in free cash flow against $1.90B in total assets and $970.5M in total debt. Key quantitative strengths: Established market leader in Consumer Discretionary with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is EVH trading relative to its 50-day, 200-day, and 52-week technical levels?

EVH last traded at $4.25 (-1.85% on volume of 1,302,471 shares), positioning the stock +1.19% above its 50-day simple moving average ($4.20) and +9.82% above its 200-day simple moving average ($3.87). Across its 52-week range of $2.10 to $6.89, EVH sits at the 44.9% percentile with a 14-day RSI of 49.2 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($3.72 to $4.78).

EVH Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Does EVH pay a dividend and is it safe?

Evolent Health Inc (Class A) (EVH) offers a 0% cash dividend yield ($0.00 annualized) and 1.8% total shareholder yield including buybacks. Roarable rates its payout coverage as REINVESTING IN GROWTH + BUYBACKS.

Direct Sub-Reports: EVH RQD Cockpit EVH 12M Forecast EVH Earnings & Move EVH Dividends & DRIP EVH Insiders & 13F EVH Whale Options EVH Profit Sankey EVH News & Why